Adverse events at post‐treatment ‐ not reported · adults with anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant satisfaction Indexed by a mix of qualitative and quantitative self‐report measures · adults with anxiety disorders
1 finding from 1 review
Disorder‐specific anxiety symptom severity at post‐treatment Indexed by a range of disorder‐specific self‐report measures · patients with anxiety disorders
1 finding from 1 review
Anxiety · patients with anxiety disorders
1 finding from 1 review
Quality of life at post‐treatment Indexed by self‐report measures of quality of life or functional disability · patients with anxiety disorders
1 finding from 1 review
Adverse events at post‐treatment not reported · patients with anxiety disorders
1 finding from 1 review
Participant satisfaction Indexed by a mix of qualitative and quantitative self‐report measures · patients with anxiety disorders
1 finding from 1 review
Clinically important improvement in anxiety at post‐treatment Indexed by a standardized interview or clinically accepted measure cut‐off score1 · patients with anxiety disorders
1 finding from 1 review
Disorder‐specific anxiety symptom severity at post‐treatment Indexed by a range of disorder‐specific self‐report measures · patients with anxiety disorders
1 finding from 1 review
Anxiety · patients with anxiety disorders
1 finding from 1 review
Remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting criteria for DSM or ICD anxiety diagnosis at the end of the trial. · children and adolescents with anxiety disorders
CBT probably leads to higher remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting… compared with wait‐list (moderate certainty).
1 finding from 1 review
Lost to · children and adolescents with anxiety disorders
CBT showed no clear difference in participants lost to compared with wait‐list (low certainty).
1 finding from 1 review
Remission of anxiety diagnoses: long‐term · children and adolescents with anxiety disorders
CBT showed no clear difference in remission of anxiety diagnoses: long‐term compared with wait‐list (low certainty).
1 finding from 1 review
Remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting criteria for DSM or ICD anxiety diagnosis at the end of the trial. · children and adolescents with anxiety disorders
CBT showed no clear difference in remission of anxiety diagnoses (ITT) analysis i.e. no longer meeting… compared with active controls (moderate certainty).
1 finding from 1 review
Reduction in anxiety symptoms (parent report) post‐treatment · children and adolescents with anxiety disorders
1 finding from 1 review
Remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting criteria for DSM or ICD anxiety diagnosis at the end of the trial. · children and adolescents with anxiety disorders
CBT showed no clear difference in remission of anxiety diagnoses (ITT analysis) i.e. no longer meeting… compared with treatment (moderate certainty).
1 finding from 1 review
Treatment responseCGI‐I · people with anxiety and comorbid alcohol use disorders
It is very uncertain whether paroxetine changes treatment responseCGI‐I compared with placebo (very low certainty).
1 finding from 1 review
Symptom severity reductionLSAS · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review
Secondary outcome: acceptability of treatment · people with anxiety and comorbid alcohol use disorders
It is very uncertain whether paroxetine changes treatment acceptability compared with placebo (very low certainty).
1 finding from 1 review
Frequency of use % of heavy drinking days at the end of treatment · people with anxiety and comorbid alcohol use disorders
1 finding from 1 review